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Background: Suicidal behavior is a worldwide health problem. Tryptophan hydroxylase (TPH) is a rate limiting enzyme in the biosynthesis
of serotonergic neurotransmission. TPH-1 and TPH-2 genes encode for TPH isoforms and have been implicated as candidate genes for
suicidal behavior. The aim of this study was to evaluate the association between the genetic variants of the TPH-1 (rs21102 and 1607395) and
TPH-2 (rs4290270, rs7305115 and rs1007023) genes and suicidal behavior in a Mexican population.
Methods:Weconducted a case-control study including200 caseswith suicide attempt and263 controls. Patientswere evaluated by a trained psychiatrist
or clinical psychologists. Five polymorphisms were genotyped and assessed for allele, genotype and haplotype association with suicide attempt.
Results: The rs7305115 polymorphism of the TPH-2 gene was associated with suicidal behavior in a Mexican population in genotype
(χ2 = 6.02, df = 2, p = 0.04) and allele (OR = 1.39, 95%IC = 1.06–1.81, p = 0.01) frequencies. The THP-2 haplotypes GTA (χ2 = 5.68,
p = 0.01) and ATT (χ2 = 5.0, p = 0.02) were associated with risk for suicide attempt.
Conclusion: Our results provide evidence for an association between the rs7305115 polymorphism of the TPH-2 gene and suicidal behavior
in a Mexican population. However, more studies are necessary to replicate these results using larger samples.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
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licenses/by-nc-nd/4.0/).around the world [1]. It is estimated that by the year 2020, the
number of deaths by suicide will increase 50% with an annual
rate of 1.53million subjects [2–4]. Nowadays, there is available
evidence from genetic analyses based on family, adoption and
twin studies that explore the genetics of suicidal behavior. From
these studies the comparison of monozygotic or identical twins
with dizygotic or two egged twins has been the focus of the
search for positive evidence concerning a genetic component of
this disease [5,6].
Until now, most of the genetic studies and meta-analyses
have involved serotonin related genes because serotonin
levels and those of its metabolites are thought to play an
important role in suicidal behavior (SB) [7–11]. For
example, low levels of 5-HIAA, the metabolite of serotonin,
in CSF (cerebrospinal fluid) have been found in bothess article under the CC BY-NC-ND license (http://creativecommons.org/
able 1
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high lethality attempted suicides (MAN AND MALONE
1997). Therefore, several studies have investigated the
involvement of the tryptophan hydroxylase (TPH) gene in
genetic susceptibility to suicidal behavior [12–14]. The
principal reason for testing an association between the TPH
gene and suicidal behavior is that this enzyme is a rate
limiting factor in the biosynthesis of 5-HT neurotransmission
and plays a key role in regulating availability, turn over and
function of serotonin [15,16]. TPH has two isoforms: TPH-1,
expressed in peripheral tissues, and TPH-2, most recently
discovered and expressed predominantly in the brain [17–19].
The TPH-1 gene is located on chromosome 11p15, spans
29 Kb and has 11 exons, whereas the TPH-2 gene is located
on chromosome 12q21.1, has 11 exons and covers a region
of about 93.5 Kb (checked in gene cards on 22 March 2015).
Both genes present several polymorphisms; the most
common variants for TPH-2 are (1) a change in the base
1125 of A N T (rs4290270) in exon 9, (2) the rs7305115
polymorphism at 1077 on exon 7 and (3) the rs1007023
variant which in the role intron (boundary) exhibits a G N T
substitution. With regard to TPH-1, the most important
variants are (1) rs211102 located also in an intron with a
variation A N G with no amino acid change and (2)
rs1607395 in an intron as well, with the variation C N T
[20–23]. Various studies have suggested that the polymor-
phisms affecting TPH-1 and TPH-2 gene expression may
result in the alteration of physiological processes related to
5-hidroxytryptamine (5-HT) [24–27].
For example, Liu and et al. found differences in the
distribution of the TPH1 gene variant (A218C) when elderly
suicide victims and controls were compared [28]. To support
the importance of the study of TPH, Perround et al. found
significantly higher TPH2 mRNA levels in suicide victims
than in controls [29]. However, the information obtained in
these studies provides no conclusive results [30–32].
Therefore, we decided to analyze the association between
genetic variants of TPH-1 and TPH-2 genes and suicidal
behavior in a case-control study in a Mexican population.
1.1. PICO question
In Mexicans adults with attempted suicide do TPH1
(rs211102, rs1607395) and TPH2 (rs7305115, rs1007023,
rs4290270) gene variants exhibit significant differences
when compared with those of healthy subjects without
suicidal behavior?Male 96 36.5 82 41.0 0.97 1 0.98
Female 167 63.5 118 59.0
arital status
Single 117 44.5 85 44.5 16.53 3 0.0009
Married 124 47.2 114 57.0
Separated/divorced 10 3.8 0 0
Widowed 12 4.5 1 0.5
ocio-economic level
High 3 1.2 0 0 2.67 2 0.26
Middle 171 65.0 137 68.5
Low 89 33.8 63 31.52. Methods
2.1. Sample
The sample included 463 subjects. The comparison group
was formed by 263 subjects, all of them unrelated to suicide
attempters, physically healthy during the medical evaluation,
un-manifested psychiatric problems, and without a history ofsuicide attempts (all assessed during brief interviews
performed by clinical psychiatrists); they were recruited
randomly when they attended the Blood Donor Center in the
municipality of Comalcalco in the state of Tabasco, as
described in a previous publication [33]. The socio-
demographic characteristics are shown in Table 1.
The cases group comprised 200 patients. From these, 169
patients were consecutively recruited from the outpatient
service of the General Hospital of Comalcalco in the state of
Tabasco, Mexico. These patients had attempted suicide
between January 2011 and February 2012. In addition, 31
patients were recruited from the Academic Multidisciplinary
Division of Comalcalco (DAMC) at the Juarez Autonomous
University of Tabasco (UJAT). To reduce ethnic variation
and stratification effects, only Mexican subjects descending
from Mexican parents and grandparents were included in the
study. Also, all subjects came solely from the municipality of
Comalcalco. No differences with respect to demographic,
psychiatric and medical factors were evaluated between the
two participant centers.
2.2. Clinical evaluation
The patient group had attempted suicide between January
2013 and December 2013; the range of the attempts covered
a history from 1 to 5. Each patient was diagnosed based on
the Structured Clinical Interview for DSM-IV Axis in
Spanish, in which disorders pertaining to Axis I, II and II
were considered. Trained psychiatrists or clinical psycholo-
gists (with a master’s degree or a higher educational level)
evaluated all the patients. We defined suicide attempt as a
self-harm behavior with at least some intent to end one's life.
The psychiatric diagnosis is shown in Table 2. Subjects with
self-injury behavior, undetermined suicide attempt, or ideation
of suicide were excluded from the study based on the Scale for
Suicide Ideation in the Spanish version. Also, subjects were
excluded when they presented a history of concomitant medical
or neurological illness and intellectual disability.
On the other hand, all healthy subjects were interviewed






Psychiatric diagnosis among male and female suicide attempters in a
Mexican population.
Males Females χ2 df p value
n % n %
Schizophrenia and psychosis 15 22.3 12 12.4 59.21 4 b0.0001
Mood disorders 25 37.3 28 28.9
Stress-related disorders 6 9.0 57 58.3
Substance related disorders 18 26.9 0
Organic disorders 3 4.5 0
ig. 1. Linkage disequilibrium in TPH-2 polymorphisms (rs7305115 and
4290270).
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lifetime history of mental disorder or suicidal behavior.
2.3. Ethics statement
All subjects signed an informed consent to participate in
the study after they were given verbal and written
explanations of the research objectives; they did not receive
any economical remuneration. This study complied with the
principles convened in the Helsinki Declaration. In addition,
this study was approved by the DAMC-UJAT Ethics and
Research Committee (UJAT-DAMC-2012-02) and also
fulfilled the guidelines of STREGA, an extension of the
STROBE statement [34]. (Supplementary material).
2.4. Genotype assays
Peripheral blood samples were taken from all subjects; DNA
was extracted using the Wizard Genomic DNA Purification Kit
(Promega). All the genotypes studied were determined using a
polymerase chain reaction (PCR) end-point method. The
polymorphisms studied (rs4290270, rs211102, rs1607395,
rs7305115 and rs1007023) are available from TaqMan SNP
Genotyping Assay made to order by Applied Biosystems. We
followed the manufacturers' genotyping protocol. All genoty-
pingwere performed using a patient-blind outcome design. As a
quality control in our genotyping analyses we used random
blind duplicates that were checked for genotype concordance
(the concordance rate was 100%).
We selected 3 SNPs (single nucleotide polymorphisms) of
the TPH-2 gene. The rs7305115 variant was considered because
a positive association with suicidal behavior was shown in the
literature [35,36]. The rs4290270 polymorphism not only
exhibits a positive association, but has also been suggested to
participate in TPH-2 alternative splicing [37].
2.5. Statistical analysis
The Hardy–Weinberg equilibrium was assayed using the
test for deviation from the Hardy–Weinberg equilibrium and
test for association, both freely available from http://ihg.gsf.
de/cgi-bin/hw/hwa1.pl. The chi-squared test was used to
compare genotype and allele frequencies between groups.
We used the Haploview 4.2 program to calculate the linkage
disequilibrium of the markers and haplotype association
[38]. The power of association was analyzed with Quanto 1.2
software. As an example, in the case of rs4290270, the powerof the analysis was 0.05 [minor allele frequency = 0.423;
genetic odds ratio (RG) = 1.0; overall disease risk in the general
population (P0) = 0.04]. The level of significance was set at
0.05. To evaluate multiple comparisons, the significance level
for Bonferroni's test was established at p = 0.016 (0.05/3).3. Results
In the present study a total of 200 unrelated suicide
attempters (82 males and 118 females) were recruited; mean
age was 27.17 (SD 9.56) years old; range 14–57 years of age.
Only 9 subjects under 18 years of age were included. The
comparison group consisted of 263 subjects (96 males and 167
females); mean age was 33.72 (SD 13.24) years old; range 14–
73 years of age. 12 subjects under 18 years old were included.
The Hardy–Weinberg equilibrium was measured in all
genotyped individuals. For the TPH-1 gene, the group with
suicidal behavior satisfied the Hardy–Weinberg equilibrium
(p N 0.05) for the three polymorphisms (rs7305115, 4290270
and rs1007023). For the control group, rs1007023 did not satisfy
theHardy–Weinberg equilibrium, therefore, this polymorphism
was excluded from the study. For the THP-1 analysis, both
remaining SNPs satisfied theHardy-Weinberg equilibrium in all
cases and controls.
The linkage-disequilibrium evaluated in controls and
suicide attempt groups for variants rs7305115 and
rs4290270 of THP-2 are shown in Fig. 1. We also measured
the linkage-disequilibrium for TPH-1 which was r2 = 1.0
(Supplementary material 1).
Table 3 shows genotype and allele frequencies of TPH-1 and
TPH-2 genes in cases (n = 200) and controls (n = 263). A
positive association was observed between rs7305115 andF
rs
Table 3
Genotypes, allele counts and frequency distributions for rs211102 and rs1607395 of the TPH-1 gene and rs4290270, rs7305115 and 1007023 of the TPH-2 gene
in suicide attempters and control group in a Mexican population.
Genotype frequencies Cases Controls χ2 df p
n % n %
Gene TPH-1 rs211102
A-A 27 13.5 40 15.2 1.16 2 0.56
A-G 99 49.5 117 44.5
G-G 74 37.0 106 40.3
rs1607395
C-C 29 14.5 40 15.2 0.37 2 0.83
C-T 100 50.0 124 47.1
T-T 71 35.5 99 37.6
Gene TPH-2 rs7305115
A-A 79 39.5 77 29.3 6.02 2 0.04
A-G 90 45.0 130 49.4
G-G 31 15.5 56 21.3
rs4290270
A-A 73 36.5 85 32.3 1.74 2 0.41
A-T 85 42.5 128 48.7
T-T 42 21.0 50 19.0
Allele frequencies Cases Controls χ2 df p
n % n %
Gene TPH-1 rs211102
A 153 38.2 197 37.4 0.06 1 0.84
G 247 61.8 329 62.6
rs1607395
C 158 39.5 204 38.8 0.04 1 0.82
T 242 60.5 322 61.2
Gene TPH-2 rs7305115
A 248 62.0 284 53.9 5.96 1 0.01
G 152 38.0 242 46.1
rs4290270
A 231 57.7 298 56.6 0.11 1 0.73
T 169 42.3 228 43.4
able 4
aplotypes of TPH-1 (rs211102 and rs1607395) and THP-2 (rs7305115 and
4290270) polymorphisms per group (cases and controls) in a Mexican
opulation.
75M.L. López-Narváez et al. / Comprehensive Psychiatry 61 (2015) 72–77suicide attempt. We observed major frequencies for the AA
genotype (χ2 = 6.02,df = 2,p = 0.04) andA allele (OR = 1.39,
95%IC = 1.06–1.81, p = 0.01) in the cases group.
Next, we performed the haplotype analysis. For TPH-2 we
found significant differences in the frequency distribution of two
haplotypes (AT, GA) between cases and controls (p b 0.05).
The AT haplotype was found as a protective haplotype against
suicide attempt (χ2 = 4.36, p = 0.03), whereas GA (χ2 = 5.68,
p = 0.01) was associated with higher risk for suicide attempt
(Table 4). After a correction for multiple testing was made, only
haplotype GA remained statistically significant. In the case of








-C 0.39 0.38 0.39 0.04 0.82
-T 0.37 0.37 0.38 0.06 0.80
-T 0.23 0.23 0.22 0.29 0.58
PH-2 haplotypes
-A 0.51 0.49 0.54 2.04 0.15
-T 0.36 0.38 0.34 1.86 0.17
-T 0.05 0.04 0.07 4.36 0.03
-A 0.05 0.07 0.03 5.68 0.014. Discussion
In the present study, we analyzed the possible association
of TPH1 and TPH-2 genes variants with suicidal behavior in
a Mexican population. We have already published a
meta-analysis analyzing the association between TPH1 and
TPH2 and suicidal behavior [9]. However, to our knowledge,
the present report is the first that shows the relationship between
TPH1 and TPH2 gene variants and suicidal behavior in acase-control association study in this region of the globe. For
these variants, a haplotype analysis was performed.
The genetic analyses of the present study did not show an
association between TPH1 and suicidal behavior by allele or
genotype in the sample; however, a positive association was
observed between allele A of rs7305115 of the TPH-2 gene and
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association between various TPH-2 polymorphisms (including
rs7305115)with suicidal behavior and others psychiatric disorders
[18,39,40]. In contrast, other studies did not find any association
between TPH-2 variants and suicidality [26,29,41]. Nevertheless,
we suggest that in Mexican suicide attempters, the TPH-2
rs7305115 SNP is a genetic risk for this psychiatric problem.
When the analysis of haplotype was performed, the GA group of
TPH2 variants showed a risk factor for suicidal behavior.
However, at themoment these interpretations ofpositive outcomes
are only speculative and need to be replicated, given that the role
of the TPH-2 gene in suicidal behavior remains controversial. A
more recent meta-analysis reported a lack of association
between TPH-2 and suicidal behavior [9]; however, the
polymorphism included in the present study was not analyzed.
In addition to the possibility of false/negatives, there are
several potential reasons for the apparent discrepancy of the
results found in this study. First, related reports have studied
different ethnic groups; most of the published studies have
been conducted in Caucasian [4,39,42,43] and Asian
[10,24,28,40,41] populations. To our knowledge, this work
brings the first data on the TPH-1 gene in Mexican suicide
attempters. Another factor influencing the results may be the
gender of the sample; our study did not present data of
gender composition as in other reports [1,22].
Other limitations may be the following: (1) we only
evaluated rs211102 and rs1607395 for TPH-1 and rs4290270
and rs7305115 for TPH-2; more variants of both genes should
be examined for suicidal behavior in future studies. Further-
more, this study does not explain the mechanism by which
serotonin may influence suicidal behavior with respect to the
different TPH-1 and TPH-2 SNPs. To elucidate this mechanism
could help to understand the neurobiology of suicidal behavior
and may reveal potential targets to prevent and treat patients
suffering from this psychiatric problem. Another limitation is
sample size, the sample in this study may be too small to detect
the effect of TPH-1 and TPH-2 polymorphisms on suicide
attempters, so it is important to replicate this study in other
Mexican populations using larger samples.
5. Conclusions
In conclusion, we suggest that the rs7305115 polymorphism
of the TPH-2 gene may exhibit an association with suicide
attempt in a Mexican population. On the other hand, no
association was observed between TPH-1 variants and suicide
attempt. However, further studies are necessary to gain more
insight into the association of TPH-1 and TPH-2 gene variants
with suicidal behavior.Role of the funding source
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